Actelion To Appeal $415M Verdict Over CoTherix Buy
Actelion Ltd. plans to appeal a reduced $415 million verdict against it in a suit claiming it bought CoTherix Inc. in order to nix a drug licensing deal and preserve its...To view the full article, register now.
Already a subscriber? Click here to view full article